As shown in Figure 1, the mRNA expression levels of NFAT1, NFAT2, and NFAT4 were downregulated in patients with LC, and those of NFAT3 and NFAT5 were upregulated in patients with LC. The gene discussed is NFATC4; the disease is laryngotracheoesophageal cleft.